Patient Guide: A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 19 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07205887
Status: 🟢 Enrolling Now
Condition: Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)
Phase: PHASE2

Where You Can Participate

This study is available at 19 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Glendale, California
  • • Sacramento, California
  • • And 16 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO - Join Clinical Trial NCTNCT07205887

How to Join This Clinical Trial - NCTNCT07205887

Learn how to participate in this PHASE2 trial studying an investigational therapy for Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07205887 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 19 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85255 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 91204 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95825 - United States

Status: RECRUITING

Clinical Research Site

Fort Lauderdale, Florida 33308 - United States

Status: RECRUITING

Clinical Research Site

Lemont, Illinois 60439 - United States

Status: RECRUITING

Clinical Research Site

Hagerstown, Maryland 21740 - United States

Status: RECRUITING

Clinical Research Site

Madison, Mississippi 39110 - United States

Status: RECRUITING

Clinical Research Site

Bloomfield, New Jersey 07003 - United States

Status: RECRUITING

Clinical Research Site

Cary, North Carolina 27511 - United States

Status: RECRUITING

Clinical Research Site

Wake Forest, North Carolina 27587 - United States

Status: RECRUITING

And 9 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships